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Anti-glomerular basement membrane(GBM) antibodies are highly specific for Goodpastures disease, 
in which they are generally directed against the non-collagenous (NC1) domain of the alpha 3 chain 
of type IV collagen(alpha 3(IV)). Less commonly, antibodies may be found with reactivity toward the 
alpha 4(IV) or alpha 5(IV) chains, which together form hexamers of the triple helical structure in 
specialised basement membranes in the glomerulus and alveolus.  Generally the Goodpasture 
antigen within the hexamers are cryptic and not accessible to the immune system, unless they are 
broken down to monomers. Alterations in the complex triple helical structure allows novel epitopes 
to be exposed with subsequent antibody binding and the pathognomic feature of linear localisation 
of the antibodies along glomerular and alveolar basement membranes. 
Previous cases of atypical presentations with glomerular binding but no circulating anti-GBM 
antibodies by conventional testing have been reported.  Here we report for the first time another 
important variant of the clinical syndrome with circulating high titre anti-GBM antibodies, crescentic 
glomerulonephritis (in some cases associated with ANCA) but no linear antibody deposition by 
immunohistochemistry. Importantly, patients sera bound recombinant alpha 3(IV) and fixed primate 
kidneys with linear glomerular staining, suggesting that in the patients, the cryptic epitopes had not 
been exposed within the kidney. We have identified 4 subjects with this pattern of disease (Table 1), 
75% of whom had concurrent ANCA and 75% of whom have done well following immunosuppressive 
treatment recovering good independent renal function.  Previous reports of double positive (anti-
GBM and ANCA) patients have shown that those biopsied all showed linear staining of IgG along the 
GBM. Variations in hexamer constituents in alveolar basement membranes allowing or preventing 
antibody binding have been suggested to explain variations in pulmonary haemorrhage. Our data 
has implications for clinical diagnosis suggesting we should not rely solely on serology, but obtain 
histological confirmation of the disease pattern, as this has important prognostic information. In 
addition, it may improve our understanding of the pathophysiology of crescentic glomerulonephritis, 
induced by mechanisms other than antibody and may explain some of the variations in disease 
outcomes. 
Table 1 
Age  Gender Anti-GBM titre at 
presentation(NR<10) 
ANCA/Subtype Peak creatinine at 
presentation(mol/l) 
Last 
follow up 
creatinine 
(mol/l) 
Follow 
up/months 
79 
64 
66 
F 
M 
F 
28 
33 
359 
Yes/MPO 
Yes/MPO 
Negative 
446 
666 
271 
195 
127 
105 
11 
21 
50 
70 
 
F 200 
 
Yes/MPO 809 
 
HD 48 
 
